Patient Blood Management im OP – Patienteneigene Ressourcen gezielt schonen und nutzen

Die Medizin ist im ständigen Wandel begriffen – neue Erkenntnisse führen zu verbesserten Therapiemöglichkeiten und Behandlungsmethoden. Angesichts zunehmender Hinweise auf das potenziell relevante Nebenwirkungsspektrum allogener Blutprodukte rückt das Patient Blood Management als klinisches Maßnahmenbündel zur Steigerung der Behandlungsqualität zunehmend in den Fokus. Im operativen Bereich zielt das Patient Blood Management insbesondere darauf, patienteneigene Ressourcen gezielt zu schonen und zu nutzen. Hierzu gehören insbesondere die Minimierung des perioperativen Blutverlustes durch blutsparende chirurgische Techniken, die maschinelle Autotransfusion und algorithmusbasiertes Gerinnungsmanagement. Auch der bedarfs- und leitliniengerechte Einsatz von Erythrozytenkonzentraten sind wichtige Bestandteile des Patient Blood Managements im OP.

Von entscheidender Bedeutung für die erfolgreiche Implementierung und Umsetzung des Patient Blood Managements ist das zielgerichtete und konstruktive Zusammenarbeiten aller Beteiligten zugunsten einer bestmöglichen Patientenversorgung.

Medicine is undergoing constant change – new insights lead to improved therapies and treatments. Increasing evidence of the potentially relevant side effects of allogeneic blood products prompted the development of patient blood management programs to improve the quality of patient care.

These aim specifically to conserve and strengthen patients' resources. Intraoperative measures include the minimization of perioperative blood loss by blood saving surgical techniques, autotransfusion and algorithm-based coagulation management. The evidence-based usage of blood products is another pillar of patient blood management.

Of crucial importance for the successful implementation and realization of patient blood management is the purposeful and constructive collaborations of all parties in favor of the best possible patient care.

Key words

Patient blood management - Patients - blood management - coagulation management - autotransfusion - hemotherapy - erythrocyte concentrates - transfusion - perioperative outcome

• Literatur

• 1 Ferraris VA, Davenport DL, Saha SP et al. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 2012; 147: 49-55
• 2 Paone G, Likosky DS, Brewer R et al. Membership of the Michigan Society of Thoracic and Cardiovascular Surgeons. . Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality. Ann Thorac Surg 2014; 97: 87-93
• 3 The World Health Assembly. Resolution on availability, safety and quality of blood safety and quality of blood products (WHA 63.12). http://www.who.int/bloodsafety/transfusion_services/self_sufficiency/en/
• 4 Gombotz H, Hofmann A. Patient Blood Management: three pillar strategy to improve outcome through avoidance of allogeneic blood products. Der Anaesthesist 2013; 62: 519-527
• 5 Choi WS, Samman N. Risks and benefits of deliberate hypotension in anaesthesia: a systematic review. Int J Oral Maxillofac Surg 2008; 37: 687-703
• 6 Bechstein WO, Strey C. Moglichkeiten der lokalen und systemischen Blutstillung bei chirurgischen Eingriffen. Chirurg 2007; 78: 98-100
• 7 Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesthesia and analgesia 2009; 109: 320-330
• 8 Vorstand der Bundesärztekammer auf Empfehlung des Wissenschaftlichen Beirats: Querschnitts-Leitlinien (BÄK) zur Therapie mit Blutkomponenten und Plasmaderivaten 2014, 4. überarbeitete Auflage.
• 9 Catling S, Williams S, Freites O et al. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 2008; 63: 1332-1338
• 10 Henry DA, Carless PA, Moxey AJ et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. The Cochrane database of systematic reviews CD 001886 2011; 1
• 11 Gombotz H, Rehak PH, Shander A, Hofmann A. The second Austrian benchmark study for blood use in elective surgery: results and practice change. Transfusion 2014; 54: 2646-2657
• 12 Hofmann A, Ozawa S, Farrugia A et al. Economic considerations on transfusion medicine and patient blood management. Best practice & research 2013; 27: 59-68
• 13 The collection, testing and use of blood and blood components in Europe: 2008 Report. https://www.edqm.eu/en/blood-transfusion-reports-70.html
• 14 Hamm CW, Bassand JP, Agewall S et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European heart journal 2011; 32: 2999-3054
• 15 Holst LB, Haase N, Wetterslev J et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014; 371: 1381-1391
• 16 Hajjar LA, Vincent JL, Galas FR et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304: 1559-1567
• 17 Carson JL, Terrin ML, Noveck H et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-2462
• 18 Villanueva C, Colomo A, Bosch A et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21
• 19 Oliver JC, Griffin RL, Hannon T, Marques MB. The success of our patient blood management program depended on an institution-wide change in transfusion practices. Transfusion 2014; 54: 2617-2624
• 20 Gross I, Seifert B, Hofmann A, Spahn DR. Patient blood management in cardiac surgery results in fewer transfusions and better outcome. Transfusion Jan 6. [Epub ahead of print] 2015;